New Delhi, November 2014 – Drug alert has notice has been issued by MHRA for Zovirax Eye Ointment (aciclovir 3%) which is being manufactured by GlaxoSmithline. The Zovirax Eye Ointment is used to treat eye infections caused by herpes simplex virus. GlaxoSmithKline has recalled two batches of the ointment as a precautionary measure.
The batches with numbers 3L942 and 3M941 have been recalled. The MHRA advised that Remaining stocks [of the batches] should be quarantined and returned to the original supplier for credit as no alternative batches of the ointment are currently available and shortages are being reported. IGMPI
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…